GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » E For L Aim PCL (BKK:EFORL) » Definitions » Debt-to-EBITDA

E For L Aim PCL (BKK:EFORL) Debt-to-EBITDA : -161.17 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is E For L Aim PCL Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

E For L Aim PCL's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ฿215 Mil. E For L Aim PCL's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ฿232 Mil. E For L Aim PCL's annualized EBITDA for the quarter that ended in Mar. 2024 was ฿-3 Mil. E For L Aim PCL's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was -161.17.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for E For L Aim PCL's Debt-to-EBITDA or its related term are showing as below:

BKK:EFORL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -14.59   Med: -0.06   Max: 10.26
Current: 4.77

During the past 13 years, the highest Debt-to-EBITDA Ratio of E For L Aim PCL was 10.26. The lowest was -14.59. And the median was -0.06.

BKK:EFORL's Debt-to-EBITDA is ranked worse than
78.67% of 75 companies
in the Medical Distribution industry
Industry Median: 2 vs BKK:EFORL: 4.77

E For L Aim PCL Debt-to-EBITDA Historical Data

The historical data trend for E For L Aim PCL's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

E For L Aim PCL Debt-to-EBITDA Chart

E For L Aim PCL Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.81 -1.81 0.88 4.37 5.14

E For L Aim PCL Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -43.32 3.73 3.84 4.13 -161.17

Competitive Comparison of E For L Aim PCL's Debt-to-EBITDA

For the Medical Distribution subindustry, E For L Aim PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


E For L Aim PCL's Debt-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, E For L Aim PCL's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where E For L Aim PCL's Debt-to-EBITDA falls into.



E For L Aim PCL Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

E For L Aim PCL's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(251.136 + 217.543) / 91.153
=5.14

E For L Aim PCL's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(214.748 + 232.024) / -2.772
=-161.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


E For L Aim PCL  (BKK:EFORL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


E For L Aim PCL Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of E For L Aim PCL's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


E For L Aim PCL (BKK:EFORL) Business Description

Traded in Other Exchanges
N/A
Address
No. 432 Rajavithi Road, Bangyee Khan Sub District, Bangplad District, Bangkok, THA, 10700
E For L Aim PCL operates as a dealer and importer of medical devices and equipment and provides advertising services. It serves customers in both the government and private sectors. The company and subsidiaries' business operations involve two principle segments which are Distributor of medical devices and equipment; and Beauty treatment segments. In addition, the group is also involved providing advertising services. Geographically all the operations are carried out through the region of Thailand. The Distributor of medical devices and equipment act as a key revenue driver for the firm.

E For L Aim PCL (BKK:EFORL) Headlines

No Headlines